Prospective, interventional study on the characterization of circulatoryTumor cells and nucleic acids in patients undergoing aLung carcinoma surgery or pulmonary metastasisctomy(Pilot study)

niversitätsklinikum Freiburg - Klinik für Thoraxchirurgie0 个研究点目标入组 29 人开始时间: 2015年4月10日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•- submission of written consent from the patient after informing
•- Age = 18 years
•Diagnosis of primary lung carcinoma or pulmonary metastases
•- indication for surgical resection (atyp. Resection, lobectomy,
•Pneumonectomy, metastasisctomy)
•- In patients who are operated on a malignancy, the
•Histopathological findings including the adequate examinations
•be. No additional biopsy, examination or intervention must be within the framework
•Of the study.
•-template the written consent of the patient after informing
•- Age = 18 years
•- Patients who have neither a history nor a suspected malignancy
•(Other than basal cell carcinoma) and a lung operation due to a benign
•Cause a basic disease.

•- Diagnosis of a second (synchronous) malignoma, except basal cell carcinoma.
•- hemoglobin <8 g / dl on the morning of operation
•- Intraoperative transfusion of more than four erythrocyte concentrates
•- Diagnosis of malignancy other than basal cell carcinoma.
•- hemoglobin <8 g / dl on the morning of operation
•- Intraoperative transfusion of more than four erythrocyte concentrates. No more
•Blood collection will be taken during or on the first postoperative day.

发起方

niversitätsklinikum Freiburg - Klinik für Thoraxchirurgie